Higashi T - Search Results

1

Wnt1 induces osteoblastic changes in a well-established osteolytic skeletal metastatic model derived from breast cancer.

Sugyo A, Tsuji AB, Sudo H, Sugiura Y, Koizumi M, Higashi T. Sugyo A, et al. Among authors: higashi t. Cancer Rep (Hoboken). 2023 Dec;6(12):e1909. doi: 10.1002/cnr2.1909. Epub 2023 Oct 15. Cancer Rep (Hoboken). 2023. PMID: 37840014 Free PMC article.

2

Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide.

Jin ZH, Tsuji AB, Degardin M, Dumy P, Boturyn D, Higashi T. Jin ZH, et al. Among authors: higashi t. Cells. 2022 Nov 4;11(21):3499. doi: 10.3390/cells11213499. Cells. 2022. PMID: 36359894 Free PMC article.

3

Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors.

Aung W, Tsuji AB, Hanaoka K, Higashi T. Aung W, et al. Among authors: higashi t. World J Clin Oncol. 2022 Nov 24;13(11):880-895. doi: 10.5306/wjco.v13.i11.880. World J Clin Oncol. 2022. PMID: 36483974 Free PMC article.

4

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Hamakubo T, Higashi T. Fujiwara K, et al. Among authors: higashi t. Nucl Med Commun. 2024 Jan 1;45(1):68-76. doi: 10.1097/MNM.0000000000001775. Epub 2023 Sep 21. Nucl Med Commun. 2024. PMID: 37728607 Free PMC article.

5

Imaging assessment of photosensitizer emission induced by radionuclide-derived Cherenkov radiation using charge-coupled device optical imaging and long-pass filters.

Aung W, Tsuji AB, Rikiyama K, Nishikido F, Obara S, Higashi T. Aung W, et al. Among authors: higashi t. World J Radiol. 2023 Nov 28;15(11):315-323. doi: 10.4329/wjr.v15.i11.315. World J Radiol. 2023. PMID: 38058603 Free PMC article.

6

An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.

Tachibana T, Oyama TG, Yoshii Y, Hihara F, Igarashi C, Shinada M, Matsumoto H, Higashi T, Kishimoto T, Taguchi M. Tachibana T, et al. Among authors: higashi t. Int J Mol Sci. 2023 Dec 7;24(24):17234. doi: 10.3390/ijms242417234. Int J Mol Sci. 2023. PMID: 38139063 Free PMC article.

7

[The 44th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 47th Survey in 2021)].

Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association; Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association, et al. Among authors: higashi t. Kaku Igaku. 2023;60(1):1-12. doi: 10.18893/kakuigaku.rp.2331. Kaku Igaku. 2023. PMID: 36792223 Free article. Japanese.

8

Process to Remove the Size Variants Contained in the Antibody-Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.

Yoshii Y, Matsumoto H, Igarashi C, Tachibana T, Hihara F, Shinada M, Waki A, Yoshida S, Naito K, Ito K, Higashi T, Kurihara H, Ueno M. Yoshii Y, et al. Among authors: higashi t. Pharmaceuticals (Basel). 2023 Sep 22;16(10):1341. doi: 10.3390/ph16101341. Pharmaceuticals (Basel). 2023. PMID: 37895812 Free PMC article.

9

[The 45th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 48th Survey in 2022)].

Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association; Okazawa H, Uehara T, Kuji I, Higashi T, Yoshimura M. Subcommittee for Safety Issues of Radiopharmaceuticals, Medical Science and Pharmaceutical Committee, Japan Radioisotope Association, et al. Among authors: higashi t. Kaku Igaku. 2024;61(1):1-12. doi: 10.18893/kakuigaku.rp.2431. Kaku Igaku. 2024. PMID: 38382921 Free article. Japanese.

10

Trace Metal Impurities Effects on the Formation of [⁶⁴Cu]Cu-diacetyl-bis(N⁴-methylthiosemicarbazone) ([⁶⁴Cu]Cu-ATSM).

Shinada M, Suzuki H, Hanyu M, Igarashi C, Matsumoto H, Takahashi M, Hihara F, Tachibana T, Sogawa C, Zhang MR, Higashi T, Sato H, Kurihara H, Yoshii Y, Doi Y. Shinada M, et al. Among authors: higashi t. Pharmaceuticals (Basel). 2023 Dec 21;17(1):10. doi: 10.3390/ph17010010. Pharmaceuticals (Basel). 2023. PMID: 38275997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,891 results

Search Page